Compare uniQure N.V. Ordinary Shares (QURE) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Target Corporation — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Target Corporation trades at $157.3 (market cap $69.05B). The key difference: Target Corporation is far larger — about 46.7× uniQure N.V. Ordinary Shares's market cap, and Target Corporation pays a 3.05% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Target Corporation for 137 Days on average.
| QURE | TGT | |
|---|---|---|
Market Cap | $1.48B | $69.05B |
Volume | 2,488,780 | 3,728,482 |
Sector | Health | Consumer Staples |
52-Week High | $70.59 | $169.90 |
52-Week Low | $9.03 | $83.68 |
Typical Hold Time | 0 Days | 137 Days |
Enterprise Value | $728.62M | $82.33B |
Dividend Yield | — | 3.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Target Corporation (TGT) trades at $151.98, down 1.04% on the day, with a neutral technical outlook. The stock shows strong fundamentals with a P/E of 15.77 and consistent earnings beats in recent quarters. Recent news highlights Target's holiday price-cutting strategy to capture market share, while analyst consensus remains positive with a $166.95 price target.
Target presents a balanced investment case with solid profitability metrics (ROE 26.41%) and stable cash flow generation. Near-term catalysts include holiday sales performance and margin benefits from tariff refunds. Key risks include competitive pressures and consumer spending volatility. Wall Street maintains a bullish bias with 47% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
